LINC01895

Across TCGA pan-cancer cohorts, LINC01895 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated LINC01895 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC01895 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01895 expression acts as an unfavorable survival marker, although some lineages such as UVM and LUSC show a favorable association.

UVM, BRCA, and KIRC are the cancer types where LINC01895 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Median	II,III,IV	0.785	0.454	.005	56	view →
BRCA	DFS	Tertile	III,IV	0.590	0.804	.016	45	view →
KIRC	DFS	Tertile	III,IV	0.374	0.655	.023	36	view →
LGG	OS	Tertile	All	0.153	0.471	<.001	36	view →
READ	OS	Tertile	II,III,IV	0.287	0.829	.008	27	view →
KIRP	OS	Tertile	All	0.173	0.712	<.001	27	view →
LUSC	DFS	Tertile	II,III,IV	0.951	0.662	.011	24	view →
MESO	OS	Tertile	All	0.278	0.577	<.001	21	view →
THCA	OS	Tertile	IV	0.626	1.000	.002	21	view →
THYM	DFS	Tertile	All	0.611	0.918	.027	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
SKCM	DFS	Tertile	IV	0.111	0.647	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

LINC01895–UVM (OS)

Open the UVM breakdown →